Cargando…
Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies
Cancer cells reprogram their metabolism to meet bioenergetics and biosynthetic demands. The first observation of metabolic reprogramming in cancer cells was made a century ago (“Warburg effect” or aerobic glycolysis), leading to the classical view that cancer metabolism relies on a glycolytic phenot...
Autores principales: | Reyes-Castellanos, Gabriela, Masoud, Rawand, Carrier, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460249/ https://www.ncbi.nlm.nih.gov/pubmed/32756381 http://dx.doi.org/10.3390/biomedicines8080270 |
Ejemplares similares
-
Targeting Redox Metabolism in Pancreatic Cancer
por: Abdel Hadi, Nadine, et al.
Publicado: (2021) -
Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer
por: Masoud, Rawand, et al.
Publicado: (2020) -
Targeting KRAS in PDAC: A New Way to Cure It?
por: He, Qianyu, et al.
Publicado: (2022) -
Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2022) -
Autophagy is required for PDAC glutamine metabolism
por: Seo, Ju-Won, et al.
Publicado: (2016)